Company intelligence / Profile preview

Umay

Edmonton, Alberta, Canadaumay.rest ↗

Ownership: Private
Development stage: Other

Overview

Umay has developed and commercialized the REST device—a wearable that uses periocular warming/cooling and heart rate variability biofeedback to reduce digital eye strain symptoms and improve sleep quality. Clinical studies have shown improvements in digital eye strain symptoms (measured by OSDI, CVSS-17), sleep quality (PSQI), and stress response (STAI) after use of the device[7].

Therapeutic areas: OphthalmologyNeurology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Umay.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Umay.

Explore the full profile